ClinVar Miner

Submissions for variant NM_000031.6(ALAD):c.397G>A (p.Gly133Arg)

gnomAD frequency: 0.00005  dbSNP: rs121912980
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001851910 SCV002276203 likely pathogenic not provided 2021-08-02 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). RNA analysis indicates that this variant does not impact mRNA splicing (PMID: 2063868). Experimental studies have shown that this missense change affects ALAD protein function (PMID: 11071662, 11342419, 17236137, 19015748). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 16862). This missense change has been observed in individual(s) with clinical features of δ-aminolevulinic acid dehydratase deficiency porphyria (PMID: 2063868, 11071662). This variant is present in population databases (rs121912980, ExAC 0.02%). This sequence change replaces glycine with arginine at codon 133 of the ALAD protein (p.Gly133Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant also falls at the last nucleotide of exon 5, which is part of the consensus splice site for this exon.
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center RCV000018358 SCV003799167 likely pathogenic Porphobilinogen synthase deficiency 2022-11-14 criteria provided, single submitter clinical testing PS3, PM1, PM3
Revvity Omics, Revvity RCV000018358 SCV004238423 likely pathogenic Porphobilinogen synthase deficiency 2023-03-22 criteria provided, single submitter clinical testing
OMIM RCV000018358 SCV000038637 pathogenic Porphobilinogen synthase deficiency 1991-07-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.